Investment in Day Three Labs Inc. - Schedule of Purchase Consideration (Details) $ in Thousands	12 Months Ended
	Jul. 31, 2025 USD ($)
Schedule of Purchase Consideration [Abstract]
Cash consideration	$ 200
Accrued consideration	200
Exchange of Day Three Promissory Notes for Common Stock	2,000
Fair value of previously held interests(1)	742	[1]
Total purchase consideration	$ 3,142

[1] The Company remeasured its previously held equity interest in Day Three immediately before the Day Three Acquisition, previously accounted for under the equity method of accounting, to its fair value (determined using the implied enterprise value based on the purchase price multiplied by the ratio of the number of shares previously held to total shares, as of the acquisition date) and recognized a loss of $1.6 million recorded on the consolidated statements of operations and comprehensive loss as a loss on initial investment in Day Three upon acquisition  during the quarter ended January 31, 2024.